Eiken Chemical Co., Ltd. Reports Consolidated and Parent Earnings Results for the Year Ended Mar. 30, 2016; Provides Consolidated and Parent Earnings and Dividend Guidance for the Six Months and Full Year of Fiscal 2017
April 26, 2016
Share
Eiken Chemical Co., Ltd. reported consolidated and parent earnings results for the year ended Mar. 30, 2016. For the year, the group reported operating income of ¥3,536 million and net income attributable to shareholders of parent company of ¥2,429 million or ¥131.43 per diluted share on net sales of ¥32,163 million against operating income of ¥2,826 million and net income attributable to shareholders of parent company of ¥2,100 million or ¥115.13 per diluted share on net sales of ¥31,014 million for the same period of last year. Profit before income taxes was ¥3,390 million against ¥3,004 million for the same period of last year. Net cash provided by operating activities was ¥3,115 million against ¥3,393 million for the same period of last year. Purchase of property, plant and equipment was ¥3,097 million against ¥1,048 million for the same period of last year.
For the first half year ending Sep. 30, 2016, the group expects operating income of ¥2,080 million and net income attributable to shareholders of parent company of ¥1,530 million or ¥83.62 per share on net sales of ¥16,810 million.
For the sending Mar. 31, 2017, the group expects operating income of ¥2,710 million and net income attributable to shareholders of parent company of ¥1,820 million or ¥99.47 per share on net sales of ¥33,830 million.
For the year, the parent company reported operating income of ¥3,556 million and net income attributable to shareholders of parent company of ¥2,466 million or ¥133.44 per diluted share on net sales of ¥32,135 million against operating income of ¥2,904 million and net income attributable to shareholders of parent company of ¥2,101 million or ¥113.93 per diluted share on net sales of ¥30,984 million for the same period of last year.
For the first half year ending Sep. 30, 2016, the parent company expects operating income of ¥2,090 million and net income attributable to shareholders of parent company of ¥1,530 million or ¥83.62 per share on net sales of ¥16,730 million.
For the year ending Mar. 31, 2017, the group parent company operating income of ¥2,720 million and net income attributable to shareholders of parent company of ¥1,820 million or ¥99.47 per share on net sales of ¥33,670 million.
For the year ended Mar. 2016, the company announced an year end dividend of ¥20 per share. Scheduled date of dividend payment is June 3, 2016
For the year ending Mar. 2017, the company expects to pay a dividend of ¥20 per share each an the end of the second quarter and at the year end.
EIKEN CHEMICAL CO., LTD. is a Japan-based company principally engaged in the manufacture and sale of test drugs. Through its subsidiaries, the Company involves in the processing, manufacture, purchase and sale of test agents. The products and services include microbial testing reagents, urine testing reagents, immunoserologic testing reagents, biochemical testing reagents and instrument food environment-related media.
Eiken Chemical Co., Ltd. Reports Consolidated and Parent Earnings Results for the Year Ended Mar. 30, 2016; Provides Consolidated and Parent Earnings and Dividend Guidance for the Six Months and Full Year of Fiscal 2017